News + Filings Transactions
|
Giordano Michael F
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/24/2023 | RAPT Therapeutics, Inc. | RAPT | Grant | Stock Option (right to buy) | 12.9k | $20.93 | $270.8k | | 05/24/2023 |
| 08/12/2022 | Epizyme, Inc. | EPZM | Disposition | Common Stock, par value $0.0001 | 9k | $0.00 | $0 | | 08/12/2022 |
| 08/12/2022 | Epizyme, Inc. | EPZM | Disposition | Common Stock, par value $0.0001 | 8.1k | $0.00 | $0 | | 08/12/2022 |
| 05/25/2022 | RAPT Therapeutics, Inc. | RAPT | Grant | Stock Option (right to buy) | 8.5k | $13.64 | $115.9k | | 05/25/2022 |
| 03/31/2022 | RAPT Therapeutics, Inc. | RAPT | Grant | Stock Option (right to buy) | 3.2k | $21.99 | $70.7k | | 03/31/2022 |
| 06/11/2021 | Epizyme, Inc. | EPZM | Grant | Stock Option (Right to Buy) | 40.6k | $8.53 | $346k | | 06/11/2021 |
| 06/11/2021 | Epizyme, Inc. | EPZM | Grant | Common Stock, par value $0.0001 | 8.1k | $0.00 | $0 | | 06/11/2021 |
| 05/28/2021 | RAPT Therapeutics, Inc. | RAPT | Grant | Stock Option (right to buy) | 7.5k | $19.30 | $144.8k | | 05/28/2021 |
| 06/25/2020 | RAPT Therapeutics, Inc. | RAPT | Sale | Common Stock | 19k | $33.37 | $634.5k | | 06/25/2020 |
| 06/25/2020 | RAPT Therapeutics, Inc. | RAPT | Exercise | Stock Option (right to buy) | 10.1k | $6.18 | $62.2k | | 06/25/2020 |
| 06/25/2020 | RAPT Therapeutics, Inc. | RAPT | Exercise | Stock Option (right to buy) | 8.9k | $12.00 | $107.3k | | 06/25/2020 |
| 06/18/2020 | RAPT Therapeutics, Inc. | RAPT | Grant | Stock Option (right to buy) | 7.5k | $28.27 | $212k | | 06/18/2020 |
| 05/29/2020 | Epizyme, Inc. | EPZM | Grant | Stock Option (Right to Buy) | 14k | $17.55 | $245.9k | | 05/29/2020 |
| 10/30/2019 | RAPT Therapeutics, Inc. | RAPT | Grant | Stock Option (right to buy) | 15.3k | $12.00 | $184k | | 10/30/2019 |
| 05/31/2019 | Epizyme, Inc. | EPZM | Grant | Stock Option (Right to Buy) | 17.6k | $13.74 | $242.3k | | 05/31/2019 |
| 03/08/2018 | Epizyme, Inc. | EPZM | Grant | Stock Option (Right to Buy) | 25k | $17.60 | $440k | | 03/08/2018 |
|